2024/03/28 08:00:09 | |
---|---|
Price | |
14.53 EUR | |
Difference | -0.41% (-0.06) |
ISIN | AU000000ANN9 |
Symbol | ANN |
Exchange | Frankfurt |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 1,853 EUR |
Benchmark | ASX ALL ORDINARIES INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 14.53 EUR |
High | 14.53 EUR |
Low | 14.53 EUR |
Close (prev. day) | 14.59 EUR |
VWAP | 13.69033 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
Related Futures | - |
Related Options | 358 |
Date | Headline | Download | |
2024/03/13 | Global Equity Ratings | ||
2024/02/22 | Global Equity Ratings | ||
2024/02/14 | Global Equity Ratings | ||
2024/01/23 | Global Equity Ratings | ||
2023/12/21 | Global Equity Ratings |
2024/03/28 08:00:09 | |
---|---|
Price | |
14.53 EUR | |
Difference | -0.41% (-0.06) |
ISIN | AU000000ANN9 |
Symbol | ANN |
Exchange | Frankfurt |
Currency | EUR |
Sector | Chemical / Pharmaceutical / Health |
Security type | Stock |
Market cap (m) | 1,853 EUR |
Benchmark | ASX ALL ORDINARIES INDEX |
Bid (Bid size) | - |
Ask (Ask size) | - |
Open | 14.53 EUR |
High | 14.53 EUR |
Low | 14.53 EUR |
Close (prev. day) | 14.59 EUR |
VWAP | 13.69033 EUR |
Volume (pcs) | 0 |
Trading volume | 0.00 |
Number of trades | 2 |
Last size | 0 |
6m | 1Y | 3Y | |
Perf (%) | +11.00% | -10.80% | -41.88% |
Perf (abs.) | +1.44 | -1.76 | -10.47 |
Beta | 0.71 | 0.80 | 0.74 |
Volatility | 25.44 | 28.92 | 31.27 |
Ø price 5 days | Ø volume 5 days (pcs.) | 14.30 EUR (0) |
Ø price 30 days | Ø volume 30 days (pcs.) | 14.05 EUR (4) |
Ø price 100 days | Ø volume 100 days (pcs.) | 14.27 EUR (4) |
Ø price 250 days | Ø volume 250 days (pcs.) | 14.51 EUR (7) |
YTD High | date | 15.76 EUR (2024/01/02) |
YTD Low | date | 13.54 EUR (2024/03/05) |
52 Weeks High | date | 16.98 EUR (2023/04/14) |
52 Weeks Low | date | 12.36 EUR (2023/10/26) |
Exchange | Date | Time | Price | Trading volume (mio.) | Number of trades |
Tradegate | 2024/03/28 | 22:26 | 14.78 EUR | 0.00 | 1 |
Stuttgart | 2024/03/28 | 10:34 | 14.64 EUR | 0.00 | 4 |
Hamburg | 2024/03/28 | 08:10 | 14.53 EUR | 0.00 | 1 |
Frankfurt | 2024/03/28 | 08:00 | 14.53 EUR | 0.00 | 2 |
FINRA other OTC Issues | 2024/03/21 | 20:52 | 15.05 USD | 0.05 | 1 |
Duesseldorf | 2024/03/28 | 19:30 | 14.63 EUR | 0.00 | 7 |
Berlin | 2024/03/28 | 08:08 | 14.64 EUR | 0.00 | 2 |
BX Swiss | - | - | - | 0.00 | - |
Australian Securities Exchange | 2024/03/28 | 06:10 | 24.58 AUD | 6.40 | 5,065 |
ANSELL LTD. |
- - |
678 Victoria Street, Level 3 - 3121 Richmond |
Telefon: +61-3-9270-7270 |
Fax: +61-3-9270-7300 |
E-mail: info@ansell.com |
Ansell Ltd. engages in the development, manufacture, distribution, and sale of gloves and protective personal equipment in the industrial and medical end markets. It operates through the Healthcare and Industrial segment. The Healthcare segment consists of surgical and examination gloves, healthcare safety devices, and active infection prevention products for healthcare patients and single use industrial application gloves. The Industrial segment provides multi-use hand and body protection solutions for industrial worker environments and specialty applications. The company was founded in 1893 and is headquartered in Richmond, Australia. |
Neil Salmon | Chairman of Managing Board |
Zubair Javeed | Member of Executive Committee |
Nigel Garrard | Chairman of Supervisory Board |
Christina M. Stercken | Member of Supervisory Board |
Debra Goodin | Member of Supervisory Board |
Leslie Desjardins | Member of Supervisory Board |
Morten Falkenberg | Member of Supervisory Board |
William Reilly | Member of Supervisory Board |
Ying Yan | Member of Supervisory Board |
Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.
By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer